ALNY
$ALNY
Alnylam Pharmaceuticals, Inc.
Pioneer in RNA interference therapeutics treating rare genetic diseases.
Healthcare$295.33
-0.78 (-0.26%)
Day Range$288.06 - $300.49
Prev Close$296.11
Analyst Rating
Strong Buy
27 Buy / 9 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
ALNY: RNAi Growth Meets Clinical Momentum
Alnylam ($ALNY) is showing renewed momentum after positive vutrisiran data and a technical breakout. Strong analyst coverage and solid fundamentals support upside, though valuation and policy risk warrant caution.
Apr 6, 2026